PAYX
45
-9
MAR
57
-3
KHC
15
2
KMB
30
-3
PG
43
-3
EMC
39
-3
DFS
65
-5
TRV
39
-3
EFX
41
-2
K
54
-2
NFLX
68
-5
ITW
45
-3
PFG
28
-3
PCG
64
-3
M
50
-5
BK
61
-4
JNPR
60
-2
SPG
48
-2
GS
55
-3
EQR
36
-3
PAYX
45
-9
MAR
57
-3
KHC
15
2
KMB
30
-3
PG
43
-3
EMC
39
-3
DFS
65
-5
TRV
39
-3
EFX
41
-2
K
54
-2
NFLX
68
-5
ITW
45
-3
PFG
28
-3
PCG
64
-3
M
50
-5
BK
61
-4
JNPR
60
-2
SPG
48
-2
GS
55
-3
EQR
36
-3
Financhill
Back

Hudson Global 10K Form

Sell
22

HSON
Hudson Global

Last Price:
$13.58
Seasonality Move:
-0.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HSON News And Ratings

See the #1 stock for the next 7 days that we like better than HSON

HSON Financial Statistics

Sales & Book Value

Annual Sales: $161.3M
Cash Flow: $1.3M
Price / Cash Flow: 15.44
Annual Sales: $15.72
Price / Book: 0.85

Profitability

EPS (TTM): -1.15000
Net Income (TTM): $-3.5M
Gross Margin: $80.3M
Return on Equity: -7.67%
Return on Assets: -5.87%

Hudson Global Earnings Forecast

Key Hudson Global Financial Ratios

  • The Gross Profit Margin over the past 25 years for HSON is 49.75%.
  • The Selling, General & Administrative Expenses for HSON have been equal to 47.98% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of HSON is 1.36% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Hudson Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Professional Services
Sector: Industrials
Current Symbol: HSON
CUSIP: 443787
Website: hudsonrpo.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.27
Quick Ratio: 3.07

Price-to-Earnings

Trailing P/E Ratio: 19.13
Forward P/E Ratio: 8.75

HSON Technical Analysis vs Fundamental Analysis

Sell
22
Hudson Global (HSON) is a Sell

Is Hudson Global a Buy or a Sell?

  • Hudson Global stock is rated a Sell
    The current Hudson Global [HSON] share price is $13.39. The Score for HSON is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.